Abstract Leadless pacemaker implantation represents an emerging therapeutic alternative for patients ineligible for conventional pacing systems; nevertheless, clinical experience in young children remains scarce. Individuals with 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) are susceptible to conduction abnormalities and severe hypersensitivity reactions to transvenous pacing devices.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile